Search
for
Sort by
Research 301–330 of 1000+
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model
- The Editor's Choice
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- LEKTI: Netherton Syndrome and Atopic Dermatitis
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
- MODERN BIOLOGICAL TREATMENT METHODS FOR ALOPECIA AREATA: A COMPREHENSIVE REVIEW
- Alopecia Universalis with Frequently Relapsing Nephrotic Syndrome of Infantile Onset: A Rare Presentation
- USE OF TOFACITINIB IN DIFFICULT TO TREAT CLINICALLY AMYOPATHIC DERMATOMYOSITIS
- Maintenance of Hair Follicle Immune Privilege Is Linked to Prevention of NK Cell Attack
- ROCK inhibitor Y-27632 maintains the propagation and characteristics of hair follicle stem cells.
- Interleukin 6 and STAT3 regulate p63 isoform expression in keratinocytes during regeneration
- Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Effect of immunosuppressive ppiase inhibitors, cyclosporin A, FK506, ascomycin and rapamycin on hair growth initiation
- 440 Squaric acid dibutylester, used in alopecia areata immunotherapy, promotes innate immune-driven hair growth with CD206+ macrophage accumulation in the dermis
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events
- A skin organoid-based infection platform identifies an inhibitor specific for HFMD
- ODP342 Panhypopituitarism Induced by CTLA-4 and PD-1/PD-L1 Inhibitor Immunotherapy
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- 713 Fisetin promotes differentiation, inhibits proliferative and inflammatory responses in cultured human cells and alleviates psoriasiform dermatitis in mice
- Silicate-based therapy for inflammatory dilated cardiomyopathy by inhibiting the vicious cycle of immune inflammation via FOXO signaling
- Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data